gila monster glp-1 Lessons from the Monster: and Ketogenic Diets Gila monster spit inspired a

Healthcare providers may order tests such as serum lipase/amylase or abdominal imaging if pancreatitis or gallbladder disease is suspected

Consequently, although semaglutide 2.4 mg (Wegovy) had already been approved in 2021 for chronic weight management in adults with obesity or overweight and at least one weight-related condition, the FDA has now expanded this indication to cardiovascular risk reduction in people with concurrent CVD and overweight/obesity

This post covers how these two substances interact, the potential benefits of stacking them, and the critical safety precautions you must take

Operationally, GLP-1 therapies have also increased the administrative burden